MODERNA INC
(NASDAQ: MRNA)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

106.530

-4.060 (-3.67%)
Range - - -   (-%)
Open -
Previous Close 110.590
Bid Price 138.850
Bid Volume 8
Ask Price 139.500
Ask Volume 11
Volume 3,959,359
Value -
Remark
Delayed prices. Updated at 29 Mar 2024 03:59.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis